Published April 18, 2017
| Version v1
Patent
Open
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
Files
US9623032.pdf
Files
(3.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f35f94536f682126f310a5b4e9c58080
|
3.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201414296127 A
- Patent number
- US 2014/0315866 A1
- Other
- oai:uchicago.tind.io:8155
Dates
- Patent filed
-
2014-06-04